Wells Fargo & Company Intersect Ent, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	N/A	-10,674 Closed	0 $0
Q1 2022 May 16, 2022	SELL	N/A	-11,933 Reduced 52.78%	10,674 $299,000
Q4 2021 Feb 14, 2022	SELL	N/A	-2,773 Reduced 10.93%	22,607 $617,000
Q3 2021 Nov 15, 2021	SELL	N/A	-15,644 Reduced 38.13%	25,380 $690,000
Q2 2021 Aug 16, 2021	SELL	N/A	-23,482 Reduced 36.4%	41,024 $701,000
Q1 2021 May 13, 2021	SELL	N/A	-35,939 Reduced 35.78%	64,506 $1.35 Million
Q4 2020 Feb 09, 2021	BUY	N/A	2,690 Added 2.75%	100,445 $2.3 Million
Q3 2020 Nov 05, 2020	SELL	N/A	-16,307 Reduced 14.3%	97,755 $1.59 Million
Q2 2020 Aug 13, 2020	BUY	N/A	43,104 Added 60.75%	114,062 $1.54 Million
Q1 2020 May 14, 2020	BUY	N/A	70,958 New	70,958 $842,000

About Intersect ENT, Inc.

Ticker XENT
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,461,700
Market Cap $945M

More about XENT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.